Key facts
- It has raised $4.0M; the latest was Early Stage VC ($4.0M) in Mar 2026.
- Notable investors include Progression Fund, CHAP Health Ventures, Dmitry Shevelenko, Story Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Procode AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Procode AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Procode AI
Developer of an AI-powered revenue cycle management company for surgeons in private practice. The company's platform utilizes a billing system that helps make administrative and reimbursement services more efficient, allowing surgeons to obtain more accurate revenue data at a faster rate.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2024
- Website
- tryprocode.com/
- Ownership
- Privately Held (backing)
Procode AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Procode AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Procode AI in its N-PORT filings yet. We sweep new filings monthly.